WO1998005645A1 - 4-substituted quinoline derivatives having fungicidal activity - Google Patents
4-substituted quinoline derivatives having fungicidal activity Download PDFInfo
- Publication number
- WO1998005645A1 WO1998005645A1 PCT/US1997/013090 US9713090W WO9805645A1 WO 1998005645 A1 WO1998005645 A1 WO 1998005645A1 US 9713090 W US9713090 W US 9713090W WO 9805645 A1 WO9805645 A1 WO 9805645A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- halo
- substituted
- phenyl
- formula
- Prior art date
Links
- 0 C*C(C(F)(F)F)c1c(ccc(Cl)c2)c2ncc1 Chemical compound C*C(C(F)(F)F)c1c(ccc(Cl)c2)c2ncc1 0.000 description 1
- WMJOQQZXPAPRGE-UHFFFAOYSA-N CC(c1ccnc2c1c(Cl)cc(Cl)c2)O Chemical compound CC(c1ccnc2c1c(Cl)cc(Cl)c2)O WMJOQQZXPAPRGE-UHFFFAOYSA-N 0.000 description 1
- BQFDVCSKUFXVRY-UHFFFAOYSA-N CC(c1ccnc2c1c(Cl)cc(Cl)c2)Oc(cc1)ccc1F Chemical compound CC(c1ccnc2c1c(Cl)cc(Cl)c2)Oc(cc1)ccc1F BQFDVCSKUFXVRY-UHFFFAOYSA-N 0.000 description 1
- IWISKXUDUOIEOM-UHFFFAOYSA-N Cc1cc2nccc(C#N)c2cc1 Chemical compound Cc1cc2nccc(C#N)c2cc1 IWISKXUDUOIEOM-UHFFFAOYSA-N 0.000 description 1
- GSPZRQVQAVVSTQ-UHFFFAOYSA-N Cc1ccnc2c1cccc2Cl Chemical compound Cc1ccnc2c1cccc2Cl GSPZRQVQAVVSTQ-UHFFFAOYSA-N 0.000 description 1
- IVPHNMMNLBTDRQ-UHFFFAOYSA-N Clc1cc2nccc(Br)c2cc1 Chemical compound Clc1cc2nccc(Br)c2cc1 IVPHNMMNLBTDRQ-UHFFFAOYSA-N 0.000 description 1
- AKCRQHGQIJBRMN-UHFFFAOYSA-N Nc(cccc1)c1Cl Chemical compound Nc(cccc1)c1Cl AKCRQHGQIJBRMN-UHFFFAOYSA-N 0.000 description 1
- CUUVOPPQCSQSIY-UHFFFAOYSA-N OCc1ccnc2c1ccc(Cl)c2 Chemical compound OCc1ccnc2c1ccc(Cl)c2 CUUVOPPQCSQSIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Definitions
- This invention provides novel compounds which are 4-substituted quinoline derivatives having plant fungicidal activity.
- This invention also provides compositions and combination products containing one or more compounds of this invention as the active ingredient. Some of the combination products exhibit synergistic activity against plant pathogens. This invention also provides fungicidal methods.
- This invention provides novel compounds of formula (1)
- X is CR 5 , where R 5 is H, Cl or CH 3 ;
- Y is CR 5 ' where R 5 ' is H, Cl, or Br;
- Z is 0, S, ,50, S02, NR 6 , where R 6 is H, C1-C4 alkyl, C1 . -C4 acyl, CR 7 R 8 , where R 7 and R 8 are independently H, C3 .
- R 1 -R 4 are independently H, OH, O2 , halo, I, C1-C4 alkyl, C3-C4 branched alkyl, C1-C4 alkoxy, halo C1-C4 alkyl, halo C1-C4 alkoxy, or halo C1-C4 alkylthio, or R 1 and R ⁇ or R ⁇ and R 3 together combine to form a carbocyclic ring containing four to six carbon atoms;
- V is CR 7 R 8 where R 7 and R 8 are independently H, C1-C4 alkyl, C1-C4 alkenyl, C2-C4 alkynyl, C1-C4 acyl,
- CN optionally substituted phenoxy, halo C,-C 4 alkyl, or OH, or R 7 and R 8 together combine to form a carbocyclic ring containing four to six carbon atoms ;
- R 9 -R 13 are independently H, CN, NO2, OH, halo, Ci- C 4 alkyl, C 3 -C4 branched alkyl, C 2 -C 4 alkanoyl, halo C - C ⁇ alkyl, hydroxy C1-C7 alkyl, C 1 -C 7 alkoxy, halo C1 . -C 7 alkoxy, C1-C7 alkylthio, halo C1-C7 alkylthio, phenyl, substituted phenyl, phenoxy, substituted phenoxy, phenylthio, substituted phenylthio, phenyl C1 .
- R 9 -C4 alkyl substituted phenyl C1-C4 alkyl, benzoyl, SiR 20 R 21 R 22 or OSiR 20 R 21 R 22 , where R 20 ,R 21 , and R 22 are H, a Ci-C ⁇ straight chain or branched alkyl group, phenyl, or substituted phenyl, provided that at least one of R 20 , R 21 , and R 22 is other than H, or R 11 and R 12 or R 12 and R 13 combine to form a carbocyclic ring, provided that unless all of R 9 -R 13 are H or F, then at least two of R 9 -R 13 are H;
- R 14 is H, halo, halomethyl, CN, NO2 , C1-C4 alkyl, C3-C4 branched alkyl, phenyl, or C1-C4 alkoxy ;
- R 15 is H, halo, halomethyl, CN, NO2 , C1-C4 alkyl, C3-C4 branched alkyl, phenyl, or C1-C4 alkoxy;
- R 16 is H, halo, halomethyl, CN, NO2 , C1-C4 alkyl, C3-C4 branched alkyl, phenyl, substituted phenyl, or C3.-C4 alkoxy
- J is N or CH and G is O, NR 19 or CH, provided that either J is N or G is NR 19 , where R 19 is H, C1-C4 alkyl, C3 . -C4 acyl, phenylsulfonyl , or substituted phenylsulfonyl ;
- halo used alone or in combination with other terms, refers to F, Cl, or Br.
- alkyl refers to a straight chain alkyl radical .
- branched alkyl refers to all alkyl isomers containing the designated number of carbon atoms, except the straight chain isomers.
- alkoxy refers to a straight or branched chain alkoxy group.
- halo alkyl refers to a straight or branched alkyl group, substituted with one or more halo atoms .
- halo alkoxy refers to an alkoxy group, substituted with one or more halo atoms.
- halo alkylthio refers to a straight or branched alkylthio group, substituted with one or more halo atoms .
- acyl refers to straight or branched chain alkanoyl .
- substituted phenyl refers to phenyl substituted with up to three groups selected from halo, Ci-Cio alkyl, branched C3-C6 alkyl, halo C 1 -C7 alkyl, hydroxy C 1 -C 7 alkyl, C 1 -C7 alkoxy, halo C 1 -C 7 alkoxy, phenoxy, phenyl, NO 2 , OH, CN, C 1 -C 4 alkanoyloxy, or benzyloxy .
- substituted phenoxy refers to a phenoxy group substituted with up to three groups selected from halo, C 1 -C 1 0 alkyl, branched C 3 -C 6 alkyl, halo C 1 -C 7 alkyl, hydroxy C 1 -C7 alkyl, C 1 -C 7 alkoxy, halo C1-C 7 alkoxy, phenoxy, phenyl, NO 2 , OH, CN, C 1 -C 4 alkanoyloxy, or benzyloxy.
- substituted phenylthio refers to a phenylthio group substituted with up to three groups selected from halo, C1-C10 alkyl, branched C 3 -C 6 alkyl, halo C1-C7 alkyl, hydroxy C 3. -C7 alkyl, C 1 -C7 alkoxy, halo C 1 -C7 alkoxy, phenoxy, phenyl, NO2, OH, CN, C 1 -C4 alkanoyloxy, or benzyloxy.
- substituted phenylsulfonyl refers to a phenylsulfonyl group substituted with up to three groups selected from halo, I , C1-C10 alkyl, C3-C6 branched alkyl, halo C1-C7 alkyl, hydroxy C1-C7 alkyl, C1-C7 alkoxy, halo-C ⁇ -C7 alkoxy, phenoxy, phenyl, O2 , OH, CN, C1-C4 alkanoyloxy, or benzyloxy.
- saturated hydrocarbon chain refers to a hydrocarbon chain containing one to three multiple bond sites.
- carrier ring refers to a saturated or unsaturated ring of four to seven carbon atoms.
- X is CR 5 wherein R 5 is H ;
- Y is CR 5 wherein R 5 is H
- R ] -R 4 are independently H, halo, or C,-C 4 alkyl, or more preferably halo;
- V is CH or C,-C 4 alkyl
- A is a phenyl group of formula (2), above, wherein R'R" are independently halo, C,-C alkyl, or halo C1-C7 alkyl, or more preferably a phenyl group of formula (2) above, wherein R'R 1J is independently halo; a pyridyl or substituted pyridyl group; or a pyrimidinyl or substituted pyrimidinyl group.
- the compounds of formula (1) have been found to control fungi, particularly plant pathogens. When employed in the treatment or prevention of plant fungal diseases, the compounds are applied to seeds or plants in a disease-inhibiting and phytologically-acceptable amount.
- disease-inhibiting and phytologically-acceptable amount refers to an amount of a compound of the invention which kills or inhibits the plant disease for which control is desired, but is not significantly toxic to the plant. This amount, will generally be from about 1 to 1000 pp , with 10 to 500 pp being preferred. The exact concentration of compound required varies with the fungal disease to be controlled, the type of formulation employed, the method of application, the particular plant species, climate conditions, and the like. The compounds of this invention may also be used to protect stored grain and other non-plant loci from fungal infestation.
- the compounds of the present invention have been found to control fungi, particularly plant pathogens.
- the compounds When employed in the treatment of plant fungal diseases, the compounds are applied to the plants in a disease inhibiting and phytologically acceptable amount.
- disease inhibiting and phytologically acceptable amount refers to an amount of a compound of the present invention which kills or inhibits the plant disease for which control is desired, but is not significantly toxic to the plant. This amount will generally be from about 1 to 1000 ppm, with 10 to 500 ppm being preferred.
- the exact concentration of compound required varies with the fungal disease to be controlled, the type formulation employed, the method of application, the particular plant species, climate conditions and the like.
- a suitable application rate is typically in the range from about 0.10 to about 4 lb/A.
- the compounds of the invention may also be used to protect stored grain and other non-plant loci from fungal infestation.
- test compounds were formulated for application by foliar spray.
- the following plant pathogens and their corresponding plants were employed.
- test inoculum for wheat powdery mildew (E. graminis f . ⁇ . tri tici ) was produced in vivo on stock plants in the greenhouse. The test plants were inoculated by dusting spores from stock plants on test plants 24 hours after spray application
- test plants were kept in the greenhouse for seven days, until disease on the untreated control plants was fully developed. Seven days after inoculation, the disease incidence on the leaves was assessed visually.
- control + 50-100%
- the compounds of this invention are made using well known chemical procedures.
- the required starting materials are commercially available, or readily synthesized utilizing standard procedures, several of which are disclosed in U.S. Patent 5,145,843.
- the compounds of formula (1) are then prepared by treatment of the corresponding 4-V substituted lepidine derivative with the appropriate -Z-A containing derivative .
- the following nonlimiting examples further illustrate this invention.
- Extractions were performed periodically as the aqueous layer neared neutral and finally at pH 10 to give a total of 5X500 ml aliquots.
- the organics were combined, dried (magnesium sulfate) , filtered through a plug of silica gel, and concentrated under vacuum to a total volume of 1 L, then heated until solid dissolved and left to crystallize 12 hours. Filtration gave analytically pure product (46 g, 65%) while concentration of the mother liquor gave spectroscopically clean product (14 g, 20%, mp 131°C) .
- the aldehyde (100 mg, 0.44 mmol) was dissolved in toluene (6 ml) and cooled to 0°C .
- Methylmagnesium bromide (1.4 M in toluene/tetrahydrofuran) was dripped in until the starting material was exhausted as judged by TLC.
- the reaction was diluted with ethylacetate (50 ml) and 0.5 N HC1 (50 ml) and allowed to warm to ambient temperature.
- the organic layer was additionally extracted with 0.5 N HC1 (3X50 ml).
- Neat diethyl azodicarboxylate (0.30 ml, 1.9 mmol) was added to a solution of secondary alcohol (300 mg, 1.25 mmol), triphenylphosphine (600 mg, 2.3 mmol), and 4-fluorophenol (200 mg, 1.7 mmol) in chloroform (6 ml ) over 15 minutes.
- the reaction was allowed to stir for two hours, concentrated under vacuum and purified by medium pressure chromatography, (10:1, heptane/ethyl acetate) . the resulting solid was recrystalized from pentane to give the phenoxy lepidine (325 mg, 78%, mp 101°C) .
- reaction was diluted with water and extracted with ethyl acetate. The organic layer was dried over magnesium sulfate, filtered and evaporated in vacuo .
- the organic layer was dried (MgS ⁇ 4) and concentrated to a white solid.
- the solid was taken up in a methanol /dichloromethane solution (1:1, 400 ml) and cooled to -78°C. Ozone was passed through the system until the reaction was complete as determined by GCMS .
- Thiourea was added (5.0 g, 600 mmol) and left to warm to ambient temperature.
- the reaction was diluted with dichloromethane and filtered through a plug of silica gel eluting with methanol/dichloromethane (1:1) .
- the solution was cooled to 0°C and sodium borohydride was added as a solid over one hour until the reaction was deemed complete by GCMS.
- the reaction was quenched and washed with IN hydrochloric acid.
- the aqueous layers were combined and filtered through a plug of cotton and then neutralized with sodium bicarbonate.
- a 200 ml stainless steel autoclave was loaded with 4-bromo-7-chloroquinoline (1.2 g, 5.0 mmol) (Can. Pat. CA 94-2133620 941004), bis (triphenylphosphine) palladium chloride (0.1 g) , triethylamine (3 ml) and ethanol (40 ml) and pressurized to 200 psi with carbon monoxide.
- the autoclave was heated at 120°C for 12 hours, cooled, and vented. Solids were removed by filtration through celite and the mother liquor concentrated in vacuo.
- 2-chloroaniline 200 g, 1.56 mol was dissolved in 600 ml ethanol, and dry HCl gas was bubbled through for 10 minutes to give 2- chloroaniline hydrochloride .
- a new flask was charged with 2-chloroaniline hydrochloride (130 g, 0.793 mol), ferric chloride hexahydrate (25.7 g, 0.095 mol), anhydrous zinc chloride (10.9 g, 0.0799 mol) and 500 ml 2B ethanol.
- the mixture was heated to 60°C for 10 minutes and 1 , 3 , 3-trimethoxy butane was added dropwise over a period of one hour.
- the mixture was then refluxed for two hours and allowed to stand overnight at room temperature.
- the 8-chlorolepidine (20. Og, 0.113 mol) and N-bromosuccinimide, (20.0 g, 0.113 mol) were dissolved in 200 ml dry carbon tetrachloride and the mixture stirred under nitrogen for three hours, while being exposed to a 250 watt high intensity sun lamp. The solution was cooled to room temperature, ⁇ filtered, and evaporated to dryness . The residue was placed over a silica gel column using ethyl acetate/pentane, to give the bromomethyl lepidine (10.8 g, 37.4 % yield, mp : 92°C) .
- reaction mixture was cooled to 0°C and 10% aqueous hydrochloric acid (3 ml) was added and the mixture stirred at room temperature until cleavage of the trimethyl silyl ether was complete as indicated by thin layer chromatography (1 h) .
- the reaction mixture was partitioned between saturated sodium hydrogen carbonate and ethyl acetate, the layers separated and the aqueous layer extracted with an additional portion of ethyl acetate. The combined organic layers were dried
- N- (2 , 3 , 3-Trifluoro-1-propenyl) trimethylammonium iodide (10.0 g, 35.6 mmol) ( Tetrahedron Let t . 1995, 36(9), 1527) was dissolved in 70 ml of acetonitrile in a oven dried nitrogen swept 250 ml round bottomed flask. With stirring, diethylamine (15.6 g, 213 mmol) was added via syringe, the flask was fitted with a reflux condenser and stirred under nitrogen at 75-80°C for one hour.
- compositions which are important embodiments of the invention, and which comprise one or more compounds of formula (1) with a phytologically- acceptable inert carrier.
- the composition may optionally include fungicidal combinations which comprise at least 1% of one or more compounds of formula (1) with another fungicide.
- compositions are either concentrated formulations which are dispersed in water for application, or are dust or granular formulations which are applied without further treatment.
- the compositions are prepared according to procedures which are conventional in the agricultural chemical art, but which are novel and important because of the presence therein of the compounds of this invention. Some description of the formulation of the compositions will, however, be given to assure that agricultural chemists can readily prepare any desired composition.
- the dispersions in which the compounds are applied are most often aqueous suspensions or emulsions prepared from concentrated formulations of the compounds.
- Such water-soluble, water suspendable, or emulsifiable formulations are either solids usually known as wettable powders, or liquids usually known as emulsifiable concentrates or aqueous suspensions.
- Wettable powders which may be compacted to form water dispersible granules, comprise an intimate mixture of the active compound, an inert carrier and surfactants.
- the concentration of the active compound is usually from about 10% to 90%.
- the inert carrier is usually chosen from among the attapulgite clays, the montmorillonite clays, the diatomaceous earths, or the purified silicates.
- Effective surfactants comprising from about 0.5% to about 10% of the wettable powder, are found among the sulfonated lignins, the naphthalenesulfonates, alkylbenzenesulfonates , the alkyl sulfates, and non-ionic surfactants, such as, for example, ethylene oxide adducts of alkyl phenols.
- Emulsifiable concentrates of the compounds comprise a convenient concentration of a compound, such as from about 10% to about 50% of liquid, dissolved in an inert carrier, which is either a water miscible solvent or a mixture of water-immiscible organic solvents, and emulsifiers.
- a compound such as from about 10% to about 50% of liquid, dissolved in an inert carrier, which is either a water miscible solvent or a mixture of water-immiscible organic solvents, and emulsifiers.
- Useful organic solvents include aromatics, especially the high-boiling naphthalenic and olefinic portions of petroleum such as heavy aromatic naphtha. Other organic solvents may also be used, such as, for example, terpenic solvents, including rosin derivatives, aliphatic ketones, such as cyclohexanone, and complex alcohols, such as 2- ethoxyethanol .
- Aqueous suspensions comprise suspensions of water- insoluble compounds of this invention, dispersed in an aqueous vehicle at a concentration in the range from about 5% to about 50%.
- Suspensions are prepared by finely grinding the compound, and vigorously mixing it into a vehicle comprised of water and surfactants chosen from the same types discussed above.
- Inert ingredients such as inorganic salts and synthetic or natural gums, may also be added, to increase the density and viscosity of the aqueous vehicle. It is often most effective to grind and mix the compound at the same time by preparing the aqueous mixture, and homogenizing it in an implement such as a sand mill, ball mill, or piston-type homogenizer.
- the compounds may also be applied as granular compositions, which are particularly useful for applications to the soil.
- Granular compositions usually contain from about 0.5% to about 10% of the compound, dispersed in an inert carrier which consists entirely of in large part of clay or a similar inexpensive substance.
- Such compositions are usually prepared by dissolving the compound in a suitable solvent, and applying it to a granular carrier which a] as been pre-formed to the appropriate particle size, in the range of from about 0.5 to 3 mm.
- Such compositions may also be formulated by making a dough or past of the carrier and compound, and crushing and drying to obtain the desired granular particle.
- Dusts containing the compounds are prepared simply by intimately mixing the compound in powdered form with a suitable dusty agricultural carrier, such as, for example, kaolin clay, ground volcanic rock, and the like. Dusts can suitably contain from about 1% to about 10% of the compound.
- a suitable dusty agricultural carrier such as, for example, kaolin clay, ground volcanic rock, and the like. Dusts can suitably contain from about 1% to about 10% of the compound.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9711110A BR9711110A (en) | 1996-08-01 | 1997-07-31 | 4-substituted quinoline derivatives having fungicidal activity |
EP97936228A EP0925282A1 (en) | 1996-08-01 | 1997-07-31 | 4-substituted quinoline derivatives having fungicidal activity |
JP50798998A JP2001508029A (en) | 1996-08-01 | 1997-07-31 | 4-substituted quinoline derivatives having fungicidal and fungicidal activity |
CA002261916A CA2261916A1 (en) | 1996-08-01 | 1997-07-31 | 4-substituted quinoline derivatives having fungicidal activity |
AU38948/97A AU723758B2 (en) | 1996-08-01 | 1997-07-31 | 4-substituted quinoline derivatives having fungicidal activity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2290796P | 1996-08-01 | 1996-08-01 | |
US60/022,907 | 1996-08-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998005645A1 true WO1998005645A1 (en) | 1998-02-12 |
WO1998005645A9 WO1998005645A9 (en) | 1998-08-20 |
Family
ID=21812051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/013090 WO1998005645A1 (en) | 1996-08-01 | 1997-07-31 | 4-substituted quinoline derivatives having fungicidal activity |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0925282A1 (en) |
JP (1) | JP2001508029A (en) |
KR (1) | KR20000029694A (en) |
CN (1) | CN1228084A (en) |
AU (1) | AU723758B2 (en) |
BR (1) | BR9711110A (en) |
CA (1) | CA2261916A1 (en) |
WO (1) | WO1998005645A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9604997B2 (en) | 2012-12-20 | 2017-03-28 | Aldeyra Therapeutics, Inc. | Peri-carbinols |
US9814701B2 (en) | 2009-12-11 | 2017-11-14 | Aldeyra Therapeutics, Inc. | Compositions and methods for the treatment of macular degeneration |
US10213395B2 (en) | 2013-01-23 | 2019-02-26 | Aldeyra Therapeutics, Inc. | Toxic aldehyde related diseases and treatment |
US10414732B2 (en) | 2017-03-16 | 2019-09-17 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
US10550085B2 (en) | 2015-08-21 | 2020-02-04 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
US10913722B2 (en) | 2005-05-26 | 2021-02-09 | Aldeyra Therapeutics, Inc. | Compositions and methods of treating retinal disease |
US11040039B2 (en) | 2017-10-10 | 2021-06-22 | Aldeyra Therapeutics, Inc. | Treatment of inflammatory disorders |
US11129823B2 (en) | 2016-05-09 | 2021-09-28 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
US11312692B1 (en) | 2018-08-06 | 2022-04-26 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024040639A1 (en) * | 2022-08-23 | 2024-02-29 | 青岛农业大学 | Quinoline-2,3-fused nine-membered ring skeleton compound, preparation method therefor and use thereof as active ingredient in plant bactericide |
US11839216B1 (en) | 2022-08-23 | 2023-12-12 | Qingdao Agricultural University | Quinoline-2,3-fused nine-membered ring scaffold compound, and preparation method and application thereof as effective component in plant fungicide |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3702039A1 (en) * | 1986-01-29 | 1987-07-30 | Sandoz Ag | Novel amine derivatives, processes for their preparation, and their use |
EP0326331A2 (en) * | 1988-01-29 | 1989-08-02 | DowElanco | Substituted quinolines and cinnolines |
EP0326328A2 (en) * | 1988-01-29 | 1989-08-02 | DowElanco | Quinoline, quinazoline, and cinnoline derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0000896B1 (en) * | 1977-08-19 | 1982-10-13 | Sandoz Ag | Propenyl amines, processes for their production and pharmaceutical compositions containing them |
-
1997
- 1997-07-31 WO PCT/US1997/013090 patent/WO1998005645A1/en not_active Application Discontinuation
- 1997-07-31 CA CA002261916A patent/CA2261916A1/en not_active Abandoned
- 1997-07-31 CN CN97196937A patent/CN1228084A/en active Pending
- 1997-07-31 BR BR9711110A patent/BR9711110A/en unknown
- 1997-07-31 EP EP97936228A patent/EP0925282A1/en not_active Withdrawn
- 1997-07-31 JP JP50798998A patent/JP2001508029A/en active Pending
- 1997-07-31 AU AU38948/97A patent/AU723758B2/en not_active Ceased
- 1997-07-31 KR KR1019997000773A patent/KR20000029694A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3702039A1 (en) * | 1986-01-29 | 1987-07-30 | Sandoz Ag | Novel amine derivatives, processes for their preparation, and their use |
EP0326331A2 (en) * | 1988-01-29 | 1989-08-02 | DowElanco | Substituted quinolines and cinnolines |
EP0326328A2 (en) * | 1988-01-29 | 1989-08-02 | DowElanco | Quinoline, quinazoline, and cinnoline derivatives |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10913722B2 (en) | 2005-05-26 | 2021-02-09 | Aldeyra Therapeutics, Inc. | Compositions and methods of treating retinal disease |
US11724987B2 (en) | 2005-05-26 | 2023-08-15 | Aldeyra Therapeutics, Inc. | Compositions and methods of treating retinal disease |
US9814701B2 (en) | 2009-12-11 | 2017-11-14 | Aldeyra Therapeutics, Inc. | Compositions and methods for the treatment of macular degeneration |
US9604997B2 (en) | 2012-12-20 | 2017-03-28 | Aldeyra Therapeutics, Inc. | Peri-carbinols |
US11007157B2 (en) | 2013-01-23 | 2021-05-18 | Aldeyra Therapeutics, Inc. | Toxic aldehyde related diseases and treatment |
US11701331B2 (en) | 2013-01-23 | 2023-07-18 | Aldeyra Therapeutics, Inc. | Toxic aldehyde related diseases and treatment |
US10588874B2 (en) | 2013-01-23 | 2020-03-17 | Aldeyra Therapeutics, Inc. | Toxic aldehyde related diseases and treatment |
US10543181B2 (en) | 2013-01-23 | 2020-01-28 | Aldeyra Therapeutics, Inc. | Toxic aldehyde related diseases and treatment |
US11771664B2 (en) | 2013-01-23 | 2023-10-03 | Aldeyra Therapeutics, Inc. | Toxic aldehyde related diseases and treatment |
US10213395B2 (en) | 2013-01-23 | 2019-02-26 | Aldeyra Therapeutics, Inc. | Toxic aldehyde related diseases and treatment |
US10550085B2 (en) | 2015-08-21 | 2020-02-04 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
US11845722B2 (en) | 2015-08-21 | 2023-12-19 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
US11046650B2 (en) | 2015-08-21 | 2021-06-29 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
US11459300B2 (en) | 2015-08-21 | 2022-10-04 | Aldeyra Therapeutics, Inc. | Deuterated compounds and uses thereof |
US11129823B2 (en) | 2016-05-09 | 2021-09-28 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
US10414732B2 (en) | 2017-03-16 | 2019-09-17 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
US11583529B2 (en) | 2017-10-10 | 2023-02-21 | Aldeyra Therapeutics, Inc. | Treatment of inflammatory disorders |
US11040039B2 (en) | 2017-10-10 | 2021-06-22 | Aldeyra Therapeutics, Inc. | Treatment of inflammatory disorders |
US11312692B1 (en) | 2018-08-06 | 2022-04-26 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
AU723758B2 (en) | 2000-09-07 |
JP2001508029A (en) | 2001-06-19 |
EP0925282A1 (en) | 1999-06-30 |
BR9711110A (en) | 1999-08-17 |
CN1228084A (en) | 1999-09-08 |
CA2261916A1 (en) | 1998-02-12 |
AU3894897A (en) | 1998-02-25 |
KR20000029694A (en) | 2000-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3151063B2 (en) | N- (4-pyridyl or 4-quinolinyl) arylacetamide insecticides | |
EP2848616B1 (en) | Derivatives of UK-2A | |
AU6526700A (en) | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation | |
JPH09505080A (en) | Insecticidal N- (substituted arylmethyl) -4- [bis (substituted phenyl) methyl] piperidine | |
KR100514941B1 (en) | 2-Methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with carboxylic acid derivatives on the pyridine ring as fungicides | |
CA2176501A1 (en) | N-(4-pyrimidinyl)amide pesticides | |
AU723758B2 (en) | 4-substituted quinoline derivatives having fungicidal activity | |
WO1998005645A9 (en) | 4-substituted quinoline derivatives having fungicidal activity | |
US6117884A (en) | 4-substituted quinoline derivatives having fungicidal activity | |
US5556859A (en) | N-(4-pyrimidinyl)amide pesticides | |
AU2597692A (en) | Nematicidal use of 4-aralkylpyridines | |
US20020035259A1 (en) | 2-methoxyimino-2-(pyridinyloxymethyl)phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring | |
WO1999025713A1 (en) | 2-methoxyimino-2-phenyl acetamides containing a ketal- or dialkoxy substituted pyridine moiety, their preparation and their use as fungicides | |
WO2022109361A1 (en) | Fungicidal aryl amidines | |
JPH07118265A (en) | Dihydroxyquinoline derivative and agricultural and horticultural germicide | |
WO1998005646A1 (en) | 1,2-dihydroquinoline derivatives having fungicidal activity | |
JPH05202032A (en) | Pyrimidinyloxy@(3754/24)quinoline derivative, its production and agricultural and horticultural germicide containing the same as active ingredient | |
WO2022109362A1 (en) | Fungicidal aryl amidines | |
JPS61291547A (en) | Fungicidal composition | |
JPH05271222A (en) | Pyrimidinyloxy@(3754/24)thio)quinoline derivative, its production and agricultural and horticultural germicide comprising the same as active ingredient | |
JPH01165592A (en) | Pyridyl-and pyradinyl compound, production thereof, agent containing the same and use thereof as sterilizer | |
JPS62294658A (en) | Acrylic acid derivative, manufacture and fungicidal composition | |
CA2418046A1 (en) | Compounds having fungicidal activity and processes to make and use same | |
JP2003516968A (en) | Pyridine derivatives having fungicidal activity and their production and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97196937.X Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AU AZ BA BB BG BR BY CA CH CN CU CZ EE GE HU IL JP KE KG KR KZ LC LK LR LS LT MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK TJ TM TR TT UA UG UZ VN YU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 26-29, DESCRIPTION, REPLACED BY NEW PAGES 26-29 |
|
ENP | Entry into the national phase |
Ref document number: 2261916 Country of ref document: CA Ref document number: 2261916 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/001128 Country of ref document: MX Ref document number: 1019997000773 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 1998 507989 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997936228 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997936228 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997000773 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997936228 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1019997000773 Country of ref document: KR |